Posted inEmerging Market
UniQure to Seek FDA Approval for Huntington’s Disease Gene Therapy Following Regulatory Dispute
UniQure is pursuing FDA approval for its Huntington's disease gene therapy AMT-130, navigating past regulatory hurdles for this promising treatment.
